Use ATG for Stem Cell Transplantation in Hematologic Cancers

In recipients of nonrelated hematopoietic stem cell transplants, rabbit antithymocyte globulin (ATG) is associated with lower rates of chronic graft-vs-host disease. Should it be the standard of care?